
Apollo Endosurgery APEN
Annual report 2022
added 03-30-2023
Apollo Endosurgery Accounts Receivables 2011-2026 | APEN
Accounts receivable — is the amount of money owed to a company by other organizations, individuals, or the government. It arises when a company has already delivered goods, performed work, or provided services, but has not yet received payment for them.Examples of accounts receivable
- Customers have not paid invoices for delivered products
- An advance has been paid to a supplier, but goods have not yet been received
- Employees have not reported on accountable amounts
- The government must refund tax overpayments
- Outstanding loans issued
- Asset quality
Accounts receivable are part of current assets. But they are not cash — they are promises. Investors assess how realistic these promises are to be collected. The higher the share of overdue or doubtful receivables, the greater the risk of asset impairment. - Impact on cash flow
Even if a company shows a profit, the money can be "tied up" in receivables. This means profit does not turn into actual cash, and the company may face liquidity shortages. - Assessment of management efficiency
The following accounts receivable turnover ratios are commonly used:
Receivables turnover = Revenue / Average accounts receivable
(the higher — the better)
Days Sales Outstanding (DSO) = 365 / Turnover
(the fewer days — the faster customers pay)
If the DSO is constantly increasing — this is a red flag — customers are delaying payments, and money gets stuck in settlements.
Annual Accounts Receivables Apollo Endosurgery
| 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 15 M | 10.1 M | 8.22 M | 9.23 M | 11.4 M | 11.7 M | 10.5 M | 6.99 K | 727 K | 1.31 M | 234 K | 1.33 M |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 15 M | 6.99 K | 6.65 M |
Quarterly Accounts Receivables Apollo Endosurgery
| 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| - | 12.9 M | - | 11.1 M | 10.1 M | 10.3 M | 11.2 M | 9.46 M | 8.22 M | 8.22 M | 8.22 M | 8.22 M | 9.23 M | 9.23 M | 9.23 M | 9.23 M | 11.4 M | 11.4 M | 11.4 M | 11.4 M | 11.7 M | 11.7 M | 11.7 M | 11.7 M | 10.5 M | 10.5 M | 10.5 M | 10.5 M | 10.5 M | 6.99 K | 6.99 K | 6.99 K | 727 K | 727 K | 727 K | 727 K | 1.31 M | 1.31 M | 1.31 M | 1.31 M | 234 K | 234 K | 234 K | 234 K | 1.33 M | 1.33 M | 1.33 M | 1.33 M |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 12.9 M | 6.99 K | 6.4 M |
Accounts Receivables of other stocks in the Medical devices industry
| Issuer | Accounts Receivables | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
|
BIOLASE
BIOL
|
5.48 M | - | -13.19 % | $ 166 K | ||
|
AdaptHealth Corp.
AHCO
|
371 M | $ 13.19 | 0.81 % | $ 1.78 B | ||
|
Allied Healthcare Products
AHPI
|
2.37 M | - | 3.58 % | $ 2.21 M | ||
|
BioSig Technologies
BSGM
|
109 K | - | 37.08 % | $ 85.7 M | ||
|
Avinger
AVGR
|
1.01 M | - | -20.74 % | $ 369 K | ||
|
Axonics Modulation Technologies
AXNX
|
44.8 M | - | - | $ 3.31 B | ||
|
Aziyo Biologics
AZYO
|
1.73 M | - | 1.37 % | $ 20.5 M | ||
|
Cardiovascular Systems
CSII
|
39.7 M | - | 0.15 % | $ 844 M | ||
|
EDAP TMS S.A.
EDAP
|
18.6 M | $ 3.22 | -0.31 % | $ 121 M | ||
|
Conformis
CFMS
|
9.77 M | - | - | $ 16.4 M | ||
|
Dynatronics Corporation
DYNT
|
2.8 M | - | 14.99 % | $ 929 K | ||
|
Cytosorbents Corporation
CTSO
|
7.55 M | $ 0.61 | -0.33 % | $ 38 M | ||
|
Globus Medical
GMED
|
679 M | $ 93.19 | -0.54 % | $ 12.6 B | ||
|
ClearPoint Neuro
CLPT
|
6.55 M | $ 11.33 | 1.07 % | $ 321 M | ||
|
Eargo
EAR
|
1.91 M | - | - | $ 10.2 M | ||
|
Electromed
ELMD
|
24.7 M | $ 26.0 | - | $ 220 M | ||
|
Second Sight Medical Products
EYES
|
455 K | - | -0.97 % | $ 54.4 M | ||
|
GBS
GBS
|
595 K | - | -0.57 % | $ 7.12 M | ||
|
Helius Medical Technologies
HSDT
|
117 K | $ 2.09 | -1.42 % | $ 1.27 M | ||
|
LENSAR
LNSR
|
6.38 M | $ 5.28 | 1.34 % | $ 63.1 M | ||
|
Pulmonx Corporation
LUNG
|
12.1 M | $ 1.25 | -1.95 % | $ 50.9 M | ||
|
Butterfly Network
BFLY
|
20.8 M | $ 5.48 | - | $ 1.16 B | ||
|
OrthoPediatrics Corp.
KIDS
|
53.8 M | $ 15.88 | 0.38 % | $ 373 M | ||
|
Delcath Systems
DCTH
|
11.7 M | $ 10.8 | -0.37 % | $ 387 M | ||
|
Orthofix Medical
OFIX
|
136 M | $ 12.29 | -0.24 % | $ 487 M | ||
|
LivaNova PLC
LIVN
|
216 M | $ 63.05 | -0.57 % | $ 3.44 B | ||
|
IRIDEX Corporation
IRIX
|
7.61 M | $ 1.07 | -1.37 % | $ 18.1 M | ||
|
CONMED Corporation
CNMD
|
248 M | $ 37.58 | -0.77 % | $ 1.17 B | ||
|
Inspire Medical Systems
INSP
|
120 M | $ 55.14 | 0.13 % | $ 1.62 B | ||
|
Integer Holdings Corporation
ITGR
|
346 M | $ 85.43 | 0.09 % | $ 2.97 B | ||
|
Invacare Corporation
IVC
|
88 M | - | - | $ 24.7 M | ||
|
Edwards Lifesciences Corporation
EW
|
660 M | $ 83.85 | 0.47 % | $ 49 B | ||
|
Sintx Technologies
SINT
|
178 K | $ 2.42 | 3.03 % | $ 6.71 M | ||
|
MiMedx Group
MDXG
|
75.7 M | $ 3.35 | 0.3 % | $ 495 M | ||
|
Stryker Corporation
SYK
|
4.04 B | $ 328.23 | -0.24 % | $ 125 B | ||
|
NanoVibronix
NAOV
|
289 K | - | - | $ 1.08 M | ||
|
Tactile Systems Technology
TCMD
|
43.9 M | $ 23.83 | -1.69 % | $ 545 M | ||
|
TELA Bio
TELA
|
10.3 M | $ 0.82 | 2.51 % | $ 38.5 M |